Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotides: promise and reality.

I Lebedeva1, C A Stein

  • 1College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

Annual Review of Pharmacology and Toxicology
|March 27, 2001
PubMed
Summary

Antisense oligonucleotides, like phosphorothioate oligonucleotides, can inhibit gene expression. Interpreting experimental data from these bioactive molecules, particularly for bcl-2 in tumor cells, requires careful consideration of multiple mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.

The Prostate·2025
Same author

A stress-induced response complex (SIRC) shuttles miRNAs, siRNAs, and oligonucleotides to the nucleus.

Proceedings of the National Academy of Sciences of the United States of America·2018
Same author

A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells.

Nucleic acids research·2015
Same author

Metastatic adrenocortical carcinoma with a prolonged response to mitotane.

Oncology (Williston Park, N.Y.)·2014
Same author

A critical assessment of the potential of short interfering RNA therapeutics.

Drug discovery today. Technologies·2014
Same author

Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.

Cancer chemotherapy and pharmacology·2014

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Oligonucleotide Therapeutics

Background:

  • Antisense oligonucleotides (ASOs) are established tools for gene silencing.
  • Phosphorothioate oligonucleotides offer enhanced nuclease resistance and are widely used in research and clinical trials.
  • The bioactivity of ASOs suggests potential for multiple gene inhibition mechanisms.

Purpose of the Study:

  • To review challenges in interpreting experimental data from antisense oligonucleotides.
  • To discuss mechanisms of gene silencing by ASOs.
  • To highlight issues related to bcl-2 inhibition in tumor cells.

Main Methods:

  • Literature review of antisense oligonucleotide applications.
  • Analysis of gene silencing mechanisms.

Related Experiment Videos

  • Case study on bcl-2 inhibition in cancer.

    • Main Results:

    • Phosphorothioate oligonucleotides are common but highly bioactive.
    • Multiple mechanisms may contribute to gene expression inhibition by ASOs.
    • Interpreting ASO experimental data can be complex.

    Conclusions:

    • Careful interpretation of experimental data is crucial when using antisense oligonucleotides.
    • Understanding diverse mechanisms is key for effective ASO application, especially for targeting bcl-2 in tumors.